Skip to main content
. 2019 Jan 22;2019(1):CD012167. doi: 10.1002/14651858.CD012167.pub2

15.2. Analysis.

Comparison 15 Loratadine 10 mg/d versus placebo (2‐week intervention), Outcome 2 Secondary outcome 1. Physician‐assessed clinical signs: number of participants for whom treatment success was judged as good or very good 13 days after randomisation.